Whan In Pharm Co.,Ltd. (KRX:016580)

Market Cap	177.25B
Revenue (ttm)	256.32B
Net Income (ttm)	15.17B
Shares Out	15.27M
EPS (ttm)	978.53
PE Ratio	11.86
Forward PE	12.58
Dividend	300.00 (2.58%)
Ex-Dividend Date	Dec 29, 2025

Volume	4,415
Average Volume	23,511
Open	11,580
Previous Close	11,580
Day's Range	11,540 - 11,620
52-Week Range	10,050 - 13,210
Beta	0.22
RSI	57.16
Earnings Date	Nov 13, 2025

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 601
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 016580

Financial Performance

In 2024, Whan In Pharm's revenue was 259.60 billion, an increase of 12.68% compared to the previous year's 230.39 billion. Earnings were 23.38 billion, a decrease of -21.47%.